Výsledky vyhledávání

Abstract P1-17-08: High-dose chemotherapy and immunotherapy in premenopausal breast cancer patients with more than 10 axillary nodes (PBC+10N). Long-term follow-up of a phase II study

Autor: Silvio Rea, F Recchia, Giampiero Candeloro

Publikováno v: Cancer Research. 79:P1-17

Background: PBC+10N have a high risk of relapse. Experimental studies suggest that high expression of vascular endothelial growth factor (VEGF) promotes tumor progression through neoangiogenesis and that natural killer (NK) cells mediate lytic activi

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::bbbac68e2c0e3167f3a301dbf1cf7de4
https://doi.org/10.1158/1538-7445.sabcs18-p1-17-08

Zobrazit plný text záznamu

Abstract P6-16-06: Maintenance immunotherapy in estrogen receptor negative (ER-) locally advanced (LA) and/or metastatic breast cancer (MBC). Long-term follow-up of a phase II study

Autor: F Recchia, Giampiero Candeloro, Silvio Rea

Publikováno v: Cancer Research. 77:P6-16

Background: Cancer immunotherapy is revolutionizing treatment today. While MBC with estrogen receptor positive (ER+) tumors, responding or stabilizing after first line chemotherapy, may have a benefit from a maintenance endocrine therapy combined wit

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::aac82921c5c6c1525e5a6ad541bbc7fe
https://doi.org/10.1158/1538-7445.sabcs16-p6-16-06

Zobrazit plný text záznamu

Abstract P5-15-06: 10-year follow-up of adjuvant ovarian suppression in high risk premenopausal breast cancer

Autor: Michele Rosselli, F Recchia, Giampiero Candeloro, Massimo Bratta, Silvio Rea

Publikováno v: Cancer Research. 76:P5-15

Background: A large randomized study has shown the value of temporary ovarian suppression during the administration of chemotherapy in the treatment of high risk estrogen receptor positive (ER+) breast cancer (BC) (Pagani et al. N Engl J Med 2014). I

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::69855b56b79a34b6e1ed047736f0d8ac
https://doi.org/10.1158/1538-7445.sabcs15-p5-15-06

Zobrazit plný text záznamu

Anthracycline-based induction chemotherapy followed by concurrent cyclophosphamide, methotrexate and 5-fluorouracil and radiation therapy in surgically resected axillary node-positive breast cancer

Autor: Francesco Recchia, Stefano Necozione, Giovanni Luca Gravina, P. Bonfili, Silvio Rea, Mario Di Staso, Giampiero Candeloro, Ernesto Di Cesare, Alisia Cesta

Publikováno v: Molecular and Clinical Oncology. 2:473-478

The present study aimed to determine the toxicity and efficacy of 4 courses of anthracyclines-taxane (AT) chemotherapy followed by radiation therapy (XRT) concurrent with cyclophosphamide, methotrexate and 5-fluorouracil (CMF) in surgically resected

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::191ad9dc3b6a1eaaa76ad0f4efc80a80
https://doi.org/10.3892/mco.2014.269

Zobrazit plný text záznamu

Abstract P6-09-06: Estrogen (E2) suppression following diagnosis of node positive (N+) breast cancer (BC) in premenopause. Long term follow-up of a phase II study

Autor: ML Evangelista, Stefano Necozione, Alisia Cesta, Silvio Rea, Giampiero Candeloro, F Recchia, Giovambattista Desideri

Publikováno v: Cancer Research. 73:P6-09

Background: E2 plays a key role in human reproduction and in premenopausal BC growth through the induction of vascular endothelial growth factor (VEGF) and the expansion of T-Regulatory cells (T-Regs). In addition, few clinical data exist on long-ter

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::981719f7b4e44ba76b35258f26dac1ce
https://doi.org/10.1158/0008-5472.sabcs13-p6-09-06

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání